The HIV-1 Tat protein stimulates reverse transcription in vitro

被引:27
作者
Apolloni, Ann
Meredith, Luke W.
Suhrbier, Andreas
Kiernan, Rosemary
Harrich, David
机构
[1] Royal Brisbane Hosp, Queensland Inst Med Res, Div Infect Dis & Immunol, Brisbane, Qld 4029, Australia
[2] CNRS, UPR 1142, Inst Human Genet, Mol Virol Lab, Montpellier, France
关键词
Tat; reverse transcriptase; in vitro; reverse transcription;
D O I
10.2174/157016207781662443
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of Tat in HIV-1 reverse transcription has been controversial largely because different studies have observed disparate effects of the Tat protein on reverse transcription. Studies of HIV-1 lacking a functional tat gene demonstrated a decrease in reverse transcription efficiency following infection of T-cells however, in vitro recombinant Tat(1-86) has been shown to inhibit RT activity. Here we show that 20-200 nM of both N-terminally histidine-tagged recombinant Tat(1-12) and Tat(1-86) stimulated reverse transcription by HIV-1 reverse transcriptase (RT) in vitro by 2-3 fold. However, both Tat species were efficient inhibitors of RT activity at 400 nM. The lower concentrations of Tat increased reverse transcription efficiency by facilitating multiple rounds of DNA synthesis, and this increase was either not seen or reduced when Tat proteins with multiply-mutated cysteine or basic domains were used. Tat-enhanced reverse transcription occurred in a RNA-independent manner, and required formation of a Tat-RT complex. Pull-down and immunoprecipitation experiments confirmed that Tat could interact with the RT p51 subunit, and mammalian two-hybrid experiments showed interaction between Tat and both the p51 and p66 subunits. Together these results provide evidence that Tat can stimulate
引用
收藏
页码:474 / 483
页数:10
相关论文
共 41 条
[31]  
KARN J, 1995, PRACTICAL APPROACH, V2, P327
[32]   CRYSTAL-STRUCTURE AT 3.5 ANGSTROM RESOLUTION OF HIV-1 REVERSE-TRANSCRIPTASE COMPLEXED WITH AN INHIBITOR [J].
KOHLSTAEDT, LA ;
WANG, J ;
FRIEDMAN, JM ;
RICE, PA ;
STEITZ, TA .
SCIENCE, 1992, 256 (5065) :1783-1790
[33]  
MODESTI N, 1991, NEW BIOL, V3, P759
[34]   Reconstitution of retroviral fusion and uncoating in a cell-free system [J].
Narayan, S ;
Young, JAT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (20) :7721-7726
[35]   HIV-1 Tat protein and its inhibitor Ro 24-7429 inhibit lymphocyte proliferation and induce apoptosis in peripheral blood mononuclear cells from healthy donors [J].
Patki, AH ;
Lederman, MM .
CELLULAR IMMUNOLOGY, 1996, 169 (01) :40-46
[36]  
RUBEN S, 1989, J VIROL, V63, P1
[37]   Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with β-branched amino acids [J].
Sarafianos, SG ;
Das, K ;
Clark, AD ;
Ding, JP ;
Boyer, PL ;
Hughes, SH ;
Arnold, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :10027-10032
[38]   Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site [J].
Sarafianos, SG ;
Das, K ;
Ding, JP ;
Boyer, PL ;
Hughes, SH ;
Arnold, E .
CHEMISTRY & BIOLOGY, 1999, 6 (05) :R137-R146
[39]   THE HIV-1 TAT PROTEIN ACTIVATES TRANSCRIPTION FROM AN UPSTREAM DNA-BINDING SITE - IMPLICATIONS FOR TAT FUNCTION [J].
SOUTHGATE, CD ;
GREEN, MR .
GENES & DEVELOPMENT, 1991, 5 (12B) :2496-2507
[40]   Functional domains of tat required for efficient human immunodeficiency virus type 1 reverse transcription [J].
Ulich, C ;
Dunne, A ;
Parry, E ;
Hooker, CW ;
Gaynor, RB ;
Harrich, D .
JOURNAL OF VIROLOGY, 1999, 73 (03) :2499-2508